1005743-14-5

Basic information

• Product Name: 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid L-(+)-treo-2-amino-1-phenyl-1,3-propanediol salt
• Synonyms: 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid L-(+)-treo-2-amino-1-phenyl-1,3-propanediol salt
• CAS NO: 1005743-14-5
• Molecular Weight: 753.402
• Mol File: 1005743-14-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid L-(+)-treo-2-amino-1-phenyl-1,3-propanediol salt(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid L-(+)-treo-2-amino-1-phenyl-1,3-propanediol salt(1005743-14-5)
• EPA Substance Registry System: 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid L-(+)-treo-2-amino-1-phenyl-1,3-propanediol salt(1005743-14-5)

Safety Data

• Hazardous Substances Data: 1005743-14-5(Hazardous Substances Data)

Upstream product

• 28143-91-1 (1S,2S)-2-amino-1-phenyl-1,3-diol 
• 158966-92-8 montelukast 

Relevant articles and documents

Purification process of montelukast and its amine salts

It comprises a process for the purification of Montelukast, or its salts or its solvates, including any stereoisomer or mixture thereof, which comprises converting Montelukast acid or a solvate thereof, including any stereoisomer or mixtures thereof, into an amine salt selected from the group consisting of cyclohexylamine, tris-(hydroxymethyl)aminomethane, L-(+)-treo-2-amino-1-phenyl-1,3-propanediol, R-(+)-α-methylbenzylamine, and L-(+)-α-phenylglycinol salt, in the presence of an appropriate solvent. It also comprises novel salts of Montelukast, in particular, cyclohexylamine, tris-(hydroxymethyl)aminomethane, L-(+)-treo-2-amino-1-phenyl-1,3-propanediol, R-(+)-α-methylbenzylamine, and L-(+)-α-phenylglycinol salts.